Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001567619-21-017948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-05 | 2021-10-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | S - Sale+OE | $143.56 | -41.7K | 47.1K | -47% | -$5.98M |
| D | 2021-10-05 | 2021-10-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $5.04 | +41.7K | 88.8K | +88% | +$210.0K |
| D | 2021-10-05 | 2021-10-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -41.7K | 61.1K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-10-01 | S | D | 21,469 | $143.97 | 49,617 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $143.53 to $144.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-10-01 | S | D | 13,297 | $143.13 | 71,086 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $142.53 to $143.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-10-01 | S | D | 4,400 | $142.16 | 84,383 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $141.53 to $142.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-10-01 | M | A | 41,666 | $5.04 | 88,783 | D | — | — | |
| 5 | Common | Class A Common Stock | 2021-10-01 | S | D | 2,500 | $144.77 | 47,117 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $144.54 to $145.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Derivative | Stock Option (right to buy) | 2021-10-01 | M | D | 41,666 | $0.00 | 61,116 | D | $5.04 · — to 2028-11-02 | 41,666 Class A Common Stock | (F6) This option, originally for 175,000 shares, of which 113,884 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |